新型酪氨酸激酶抑制剂BGJ398对人白血病细胞株KG-1细胞的抑制作用
本研究在体外探讨泛FGFR抑制剂BGJ398对KG-1细胞的作用及机制。BGJ398呈剂量依赖性抑制增殖,1.4 µmol/L时凋亡率36.4%高于对照组4.5%(P<0.001),并下调Bcl-2、FGFR1OP2-FGFR1融合蛋白、p-AKT及p-S6K,上调caspase-3,p-ERK无明显改变。
要点
- BGJ398剂量依赖性抑制KG-1细胞增殖。
- 1.4 µmol/L BGJ398作用48 h后凋亡率36.4%,对照组4.5%(P<0.001)。
- 机制涉及下调FGFR1、Bcl-2、p-AKT及p-S6K,上调caspase-3,p-ERK无明显改变。
核心结论
- BGJ398能有效抑制KG-1细胞增殖并诱导凋亡,机制可能与抑制FGFR1表达、下调Bcl-2、促进caspase-3活化及抑制AKT和S6K磷酸化有关。
研究设计与样本
- 体外研究,以人急性髓系白血病细胞株KG-1细胞为对象,采用CCK-8法检测增殖,Annexin V-FITC检测凋亡,RQ-PCR检测凋亡相关基因,Western blot检测蛋白及信号通路磷酸化水平。
主要发现
- BGJ398呈剂量依赖性抑制KG-1细胞增殖并诱导凋亡。
- BGJ398作用48 h后Bcl-2基因表达为0.342±0.054,低于对照组1.026±0.165(t=3.94,P=0.017)。
- caspase-3基因表达为0.456±0.189,高于对照组1.008±0.091(t=16.44,P<0.001)。
- BGJ398作用组caspase-3活化蛋白增加、Bcl-2蛋白下调,FGFR1OP2-FGFR1融合蛋白及AKT、S6K1磷酸化水平下调(P值均<0.01),ERK磷酸化水平无明显改变。
- 原文结果部分英文摘要称BGJ398(1.4 µmol/L)诱导KG-1细胞凋亡36.4%,对照组4.5%(P<0.001)。
关键数值与推荐
- BGJ398(1.4 µmol/L)诱导KG-1细胞凋亡36.4%,对照组4.5%(P<0.001)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the effects and possible mechanisms of the novel pan-FGFR inhibitor BGJ398 on KG-1 cells in vitro. Methods: Effects of BGJ398 on cells proliferation were detected by CCK-8, the apoptosis was assessed by Annexin V-FITC. Reverse transcriptionquantitative polymerase chain reaction (q-PCR) analysis was used to detect the expression of apoptosis-related genes B cell lymphoma-2 (Bcl-2) and caspase-3. Western blotting analysis was performed to explore the proteins expression levels of Bcl-2, caspase-3 and the expression of p-AKT, p-S6K, p-ERK and FGFR1. Results: BGJ398 effectively inhibited cell proliferation by dose-dependent manners. BGJ398(1.4 µmol/L) induced apoptosis of KG-1 cells by 36.4%, compared with 4.5% in the control group(P<0.001). Treatment with BGJ398 at 1.4 µmol/L led to significant increases in the expression levels of caspase-3, and decreases in the expression of Bcl-2 (P<0.005). In accordance with these results, Western blot analysis further confirmed the increased expression of Bcl-2 protein along with elevated caspase-3 activity. In addition, BGJ398 markedly down-regulated FGFR1OP2-FGFR1 fusion protein, p-AKT and p-S6K expression, but not p-ERK expression. Conclusion: Novel pan-FGFR inhibitor BGJ398 substantially suppressed KG-1 cell growth and induced apoptosis by inhibiting the expression of FGFR1, p-AKT, p-S6K and regulating apoptosis-related proteins. 目的: 探讨针对FGFR1的酪氨酸激酶抑制剂BGJ398对人急性髓系白血病细胞株KG-1细胞的影响及可能的作用机制。 方法: CCK-8法检测BGJ398对KG-1细胞增殖的影响;流式细胞术Annexin Ⅴ/PI双重染色法检测BGJ398对细胞凋亡的影响;RQ-PCR检测细胞凋亡相关基因的表达;Western blot法检测凋亡相关蛋白、FGFR1OP2-FGFR1融合蛋白及信号通路分子磷酸化水平的表达变化。 结果: BGJ398能有效抑制KG-1细胞增殖,抑制率呈剂量依赖性升高,并能诱导细胞凋亡。BGJ398作用KG-1细胞48 h后,与对照组比较凋亡相关基因Bcl-2表达下降(0.342±0.054对1.026±0.165,t=3.94,P=0.017),caspase-3表达上调(0.456±0.189对1.008±0.091,t=16.44,P<0.001),差异均有统计学意义。与对照组相比,BGJ398作用组caspase-3活化蛋白表达增加,同时Bcl-2蛋白表达下调;FGFR1OP2-FGFR1融合蛋白水平及AKT、S6K1磷酸化水平下调,差异均有统计学意义(P值均<0.01),但ERK磷酸化表达水平无明显改变。 结论: BGJ398能有效抑制KG-1细胞增殖并诱导细胞凋亡,其机制可能与抑制FGFR1表达、下调Bcl-2水平、促进Caspase-3活化及抑制AKT和S6K磷酸化有关。.
引用
- Jiang Y, Chao HY, Zhang XW, et al. [Inhibitory Eefects of the novel tyrosine kinase inhibitor BGJ398 against human leukemic cell line KG-1 cells]. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29562450. doi:10.3760/cma.j.issn.0253-2727.2018.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。